L A Steffensen

1PUBLICATIONS
13CO-AUTHORS
Allergy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Oct 01, 2020
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).

A Wollenberg, A Blauvelt, E Guttman-Yassky

Pageof 1

Frequent Collaborators

1 joint publications

A Wollenberg

1 joint publications

A Blauvelt

1 joint publications

E Guttman-Yassky

1 joint publications

M Worm